|
1
|
Ornitz DM and Itoh N: The Fibroblast
Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol.
4:215–266. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hoshikawa M, Ohbayashi N, Yonamine A,
Konishi M, Ozaki K, Fukui S and Itoh N: Structure and expression of
a novel fibroblast growth factor, FGF17, preferentially expressed
in the embryonic brain. Biochem Biophys Res Commun. 244:187–191.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohbayashi N, Hoshikawa M, Kimura S,
Yamasaki M, Fukui S and Itoh N: Structure and expression of the
mRNA encoding a novel fibroblast growth factor, FGF-18. J Biol
Chem. 273:18161–18164. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu J, Lawshe A, MacArthur CA and Ornitz
DM: Genomic structure, mapping, activity and expression of
fibroblast growth factor 17. Mech Dev. 83:165–178. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Leary DD, Chou SJ and Sahara S: Area
patterning of the mammalian cortex. Neuron. 56:252–269. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong X, Tang B, Li J, Xu Q, Fang S and Hua
Z: Expression and purification of intact and functional soybean
(Glycine max) seed ferritin complex in Escherichia coli. J
Micro Biotech. 18:299–307. 2008.
|
|
7
|
Jana S and Deb JK: Strategies for
efficient production of heterologous proteins in Escherichia
coli. Appl Microbiol Biotechnol. 67:289–298. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Derynck R, Roberts AB, Winkler ME, Chen EY
and Goeddel DV: Human transforming growth factor-alpha: Precursor
structure and expression in E. coli. Cell. 38:287–297. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Verdon J, Girardin N, Marchand A, Héchard
Y and Berjeaud JM: Purification and antibacterial activity of
recombinant warnericin RK expressed in Escherichia coli.
Appl Microbiol Biotechnol. 97:5401–5412. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ajikumar PK, Xiao WH, Tyo KE, Wang Y,
Simeon F, Leonard E, Mucha O, Phon TH and Pfeifer B: Isoprenoid
pathway optimization for Taxol precursor overproduction in
Escherichia coli. Science. 330:70–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song L, Huang Z, Chen Y, Li H, Jiang C and
Li X: High-efficiency production of bioactive recombinant human
fibroblast growth factor 18 in Escherichia coli and its
effects on hair follicle growth. Appl Microbiol Biotechnol.
98:695–704. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tabarés-Seisdedos R and Rubenstein JL:
Chromosome 8p as a potential hub for developmental neuropsychiatric
disorders: Implications for schizophrenia, autism and cancer. Mol
Psychiatry. 14:563–589. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heer R, Douglas D, Mathers ME, Robson CN
and Leung HY: Fibroblast growth factor 17 is over-expressed in
human prostate cancer. J Pathol. 204:578–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nezu M, Tomonaga T, Sakai C, Ishii A,
Itoga S, Nishimura M, Matsuo Y, Tagawa M and Nomura F: Expression
of the fetal-oncogenic fibroblast growth factor-8/17/18 subfamily
in human hematopoietic tumors. Biochem Biophys Res Commun.
335:843–849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hoshikawa M, Ohbayashi N, Yonamine A,
Konishi M, Ozaki K, Fukui S and Itoh N: Structure and expression of
a novel fibroblast growth factor, FGF-17, preferentially expressed
in the embryonic brain. Biochem Biophys Res Commun. 244:187–191.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun C, Li Y, Taylor SE, Mao X, Wilkinson
MC and Fernig DG: Halo Tag is an effective expression and
solubilisation fusion partner for a range of fibroblast growth
factors. Peer J. 3:e10602015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Groot NS and Ventura S: Effect of
temperature on protein quality in bacterial inclusion bodies. FEBS
Lett. 580:6471–6476. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berman B, Ostrovsky O, Shlissel M, Lang T,
Regan D, Vlodavsky I, Ishai-Michaeli R and Ron D: Similarities and
differences between the effects of heparin and glypican-1 on the
bioactivity of acidic fibroblast growth factor and the keratinocyte
growth factor. J Biol Chem. 274:36132–36138. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee YF, Schmidt M, Graalfs H, Hafner M and
Frech C: Modeling of dual gradient elution in ion exchange and
mixed-mode chromatography. J Chromatogr A. 1417:64–72. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miraoui H, Dwyer AA, Sykiotis GP, Plummer
L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, et
al: Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are
identified in individuals with congenital hypogonadotropic
hypogonadism. Am J Hum Genet. 92:725–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meijer D, Sieuwerts AM, Look MP, van
Agthoven T, Foekens JA and Dorssers LC: Fibroblast growth factor
receptor 4 predicts failure on tamoxifen therapy in patients with
recurrent breast cancer. Endocr Relat Cancer. 15:101–111. 2008.
View Article : Google Scholar : PubMed/NCBI
|
